Acute uric acid nephropathy primary prevention

	Acute uric acid nephropathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute uric acid nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
KUB X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute uric acid nephropathy primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute uric acid nephropathy primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute uric acid nephropathy primary prevention
CDC on Acute uric acid nephropathy primary prevention
Acute uric acid nephropathy primary prevention in the news
Blogs on Acute uric acid nephropathy primary prevention
Directions to Hospitals Treating Acute uric acid nephropathy
Risk calculators and risk factors for Acute uric acid nephropathy primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients at risk for acute uric acid nephropathy should be treated with allopurinol prior to treatment with cytotoxic drugs.